Get Opioid Risk Assessment Template

A score of 2 or lower indicates low risk for future opioid use disorder; a score of >/= 3 indicates high risk for opioid use disorder. Cheatle M, Compton P, Dhingra L, Wasser T, O'Brien. Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Non-Malignant Pain.

The DIRE is a clinician-rated instrument designed for use by primary care physicians to predict the efficacy of analgesia and adherence with long-term opioid therapy. The DIRE score can range from 7 to 21, with a score of 13 or below suggesting that a patient is not a suitable candidate for long-term opioid therapy.

This tool should be administered to patients upon an initial visit prior to beginning or continuing opioid therapy for pain management. A score of 2 or lower indicates low risk for future opioid use disorder; a score of >/= 3 indicates high risk for opioid use disorder.

The Screener and Opioid Assessment for Patients with Pain (SOAPP)® is a tool for clinicians to help determine how much monitoring a patient on long-term opioid therapy might require.

The Screener and Opioid Assessment for Patients with Pain (SOAPP)® Version 1.0 is a tool for clinicians to help determine how much monitoring a patient on long-term opioid therapy might require.

The DIRE Score is a clinician rating designed for the primary care physician. It is used to predict efficacy of analgesia and patient compliance with long-term opioid analgesic treatment.

Current Opioid Misuse Measure (COMM®) Total score can range from 0–68. A score of ≥9 is suggestive of current ADRB with 77% sensitivity and 66% specificity. The COMM is one of the most commonly used tools for patients on long-term opioid therapy and has been validated by high quality studies.

It is meant to supplement other risk assessments or to diagnose a substance use disorder. It is not meant to predict abuse or addiction but to provide the clinician a sense of the probability the patient will display aberrant drug related behavior within a year if prescribed an opioid.

The DIRE is a clinician-rated instrument designed for use by primary care physicians to predict the efficacy of analgesia and adherence with long-term opioid therapy. The DIRE score can range from 7 to 21, with a score of 13 or below suggesting that a patient is not a suitable candidate for long-term opioid therapy.